Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis.
Vogelzang, Alexis; Perdomo, Carolina; Zedler, Ulrike; Kuhlmann, Stefanie; Hurwitz, Robert; Gengenbacher, Martin; Kaufmann, Stefan H E.
J Infect Dis
; 210(12): 1928-37, 2014 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-24943726
Manipulation of BCG vaccine: a double-edged sword.
The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine.
Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers.
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
[When will the new tuberculosis vaccine appear?].